Data From OECD Suggests Canada Topped the % Excess All-Cause Mortality of Any OECD Country in 2023

And we wonder why our ERs are full

By Feb 1/2, 2023 Canada had 252.13 shots per 100 population and the USA had 202.17 [Our World in DATA]. Since not all the population was ever vaccinated (90.4% in Canada and 81.4% USA, OECD stats) this index becomes 228 (Canada) over 165 (USA).

Stats Canada data of November 27, 2023 indicates Excess All-Cause Mortality (EACM) over 2019 at 23,111 in 2020; 26,339 in 2021 and a startling 48,780 in 2022. This corresponds with the turquoise shaded area in the image above showing Canada had a relative higher % EACM in 2022 over the USA not evident in either 2020 or 2021.

There may be several reasons for these observations. One, there was an incentive in the USA to use ventilators and remdesivir (NCTAP under Medicare Inpatient Prospective Payment System) which started November 2, 2020 and lasted until Sept 30, 2023 (even though the emergency ended May 11, 2023). This may have exaggerated the EACM difference of the USA to Canada after Nov 2, 2020 until April 2022. Two, more people in Canada (especially the vulnerable/aged) continued to get boosted perhaps 40% more than the USA. On face value this data implicates the third dose of the COVID-19 mRNA shot to be quite deadly in Canada relative to the USA. Most notably in Canada the second dose was postponed basically until July 2021 and the third dose may have been given shortly thereafter (perhaps 3-6 months later ?) with insufficient time to clear spike protein. The third dose along with common exposures to the first omicron wave would have resulted in high toxicity/immunosenescence in the boosted due to spike protein in Canadians while in Americans the conversion of spike-specific IgG1/3 to IgG4 reduced ADE and COVID-19 mortality (and likelihood of hospitalization).

More boosters in Canadians resulted in more toxicity/immunosenescence including clotting, myocarditis, CVD, tumors, etc. It will be important to determine if multi-boosted Canadians had higher levels of spike protein in the blood and higher levels of spike IgG1/IgG3 than the Americans (relatively speaking) in samples taken in 2022.

OECD Stats indicate for the first 44 weeks of 2023 Canada had 28,400 (prorated for 52 weeks about 33,564) at 16.2 % EACM and the USA for the first 44 weeks of 2023 at 155,783 (184,107 prorated) at 7.8% EACM which is maintaining a difference of 8.4 %. Notably Canada had the highest of OECD countries for EACM in 2023!

Is this something we should be proud of?

Clearly Stats Canada and the PHAC need to link the C19 (and other vaccines) vaccination datasets with hospitalizations and deaths to figure out where Canada went wrong in their pandemic response and to accurately determine the number of deaths associated with COVID-19 mRNA shots!